drugset / Trial / NCT04029467

Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery

NCT04029467 ↗

Phase 4 Unknown 44 enrolled Lebanese American University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients undergoing Partial or total mastectomy with axillary LN dissection will receive prior to induction of general anaesthesia ESP block at T4 level at the same side of the surgery. one group will receive ropivacaine 0.375% and the other will get ropivacaine 0.375% with dexmedetomidine 0.5mcg/kg as an adjuvant. time to first narcotic requirement will be documented and therefore an assessment of the duration of action of the block will be made

Timeline

Start
2019-07-17
Primary completion
2021-07-17
Completion
2022-01-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Other

Indications